Stocks Health care BEAT

NASDAQ · Health care

HeartBeam, Inc. (BEAT)

It posted a net loss of $20.3M. In fiscal 2025 capital spending exceeded operating cash flow by $14.6M. At June 30, 2026 it held $8.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

What HeartBeam, Inc. does

HeartBeam, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker BEAT.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What HeartBeam, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. August 14, 2026
   Material agreement 8-K
2. August 14, 2026
   Securities offering prospectus 424B5
3. August 13, 2026
   Activist stake changed SCHEDULE 13D/A
4. August 13, 2026
   Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$0.10 versus -$0.15.
5. August 6, 2026
   Executive or director change 8-K/A
6. August 3, 2026
   Shareholder vote results 8-K
7. July 2, 2026
   Stock exchange listing notice 8-K
8. June 25, 2026
   Additional proxy material DEFA14A
9. June 24, 2026
   Executive or director change 8-K
10. June 22, 2026
    Executive or director change 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 24, 2026. Insider transactions on SEC

Insider trades

What the people running HeartBeam, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 3 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns BEAT

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

4 insiders reported holding 4,945,700 shares in total, about $1.8M at the last price.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about BEAT

What does HeartBeam, Inc. do?

HeartBeam, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker BEAT.

Is HeartBeam, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $20.3M.

When did HeartBeam, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from August 14, 2026.

Similar companies

Compare BEAT with

Compare BEAT with any company

Follow BEAT

Get an email when HeartBeam, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow BEAT: get an email when it files

Where the numbers come from

Financial figures are the values HeartBeam, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.